Effects of serum uric acid levels on coronary collateral circulation in patients with non-ST elevation acute coronary syndrome

Coronary Artery Disease

Volumn 23, Issue 7, 2012, Pages 421-425

  Kasapkara, Haci Ahmet ^a   Topsakal, Ramazan ^c   Yarlioglues, Mikail ^a   Yarlioglues, Gulsum ^b   Dogdu, Orhan ^d   Ardic, Idris ^e   Akpek, Mahmut ^c   Kaya, Mehmet Gungor ^c  

^a Diskapi Training Research Hospital   (Turkey)

^b ANKARA TRAINING AND RESEARCH HOSPITAL   (Turkey)

^c ERCIYES UNIVERSITY   (Turkey)

^d Yozgat State Hospital   (Turkey)

^e Avukat Cengiz Gökçek Gaziantep Devlet Hastanesi ^*  (Turkey)

Author keywords

coronary collateral; non ST elevation acute coronary syndrome; uric acid

Indexed keywords

URIC ACID;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; CORONARY ARTERY COLLATERAL CIRCULATION; DISEASE CLASSIFICATION; FEMALE; HOSPITAL ADMISSION; HUMAN; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; NON ST SEGMENT ELEVATION ACUTE CORONARY SYNDROME; PRIORITY JOURNAL;

ACUTE CORONARY SYNDROME; AGED; BIOLOGICAL MARKERS; CHI-SQUARE DISTRIBUTION; COLLATERAL CIRCULATION; CORONARY ANGIOGRAPHY; CORONARY CIRCULATION; FEMALE; HUMANS; LINEAR MODELS; MALE; MIDDLE AGED; PATIENT ADMISSION; PROGNOSIS; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; UP-REGULATION; URIC ACID;

EID: 84867578906     PISSN: 09546928     EISSN: 14735830     Source Type: Journal    
DOI: 10.1097/MCA.0b013e32835648ba     Document Type: Article

References (34)

1. Kersten JR, Pagel PS, Chilian WM, Warltier DC. Multifactorial basis for coronary collateralization: A complex adaptive response to ischemia [review]. Cardiovasc Res 1999; 43:44-57.
2. Resnick N, Collins T, Atkinson W, Bonthron DT, Dewey CF Jr, Gimbron MA Jr. Platelet-derived growth factor B chain promoter contains a cis-acting fluid shear-stress-responsive element. Proc Natl Acad Sci USA 1993; 90:4591-4595.
3. Venema RC, Nishida K, Alexander RW, Harrison DG, Murphy TJ. Organization of the bovine gene encoding the endothelial nitric oxide synthase. Biochim Biophys Acta 1994; 1218:413-420.
4. Fang J, Alderman MH. Serum uric acid and cardiovascular mortality the NHANES I epidemiologic follow-up study, 1971-1992. National Health and Nutrition Examination Survey. JAMA 2000; 283:2404-2410.
5. Kaya MG, Uyarel H, Akpek M, Kalay N, Ergelen M, Ayhan E, et al. Prognostic value of uric acid in patients with ST-elevated myocardial infarction undergoing primary coronary intervention. Am J Cardiol 2012; 109: 486-491.
6. Erdogan D, Gullu H, Caliskan M, Yildirim E, Bilgi M, Ulus T, et al. Relationship of serum uric acid to measures of endothelial function and atherosclerosis in healthy adults. Int J Clin Pract 2005; 59:1276-1282.
7. Tavil Y, Kaya MG, Oktar SO, Sen N, Okyay K, Yazici HU, Cengel A. Uric acid level and its association with carotid intima-media thickness in patients with hypertension. Atherosclerosis 2008; 197:159-163.
8. Topsakal R, Kaya MG, Duran M, Gunebakmaz O, Dogan A, Inanc T, et al. The relation between microalbuminuria and coronary collateral vessels development in patients with unstable coronary artery disease. Coron Artery Dis 2009; 20:431-434.
9. Vasquez-Vivar J, Santos AM, Junqueira VB, Augusto O. Peroxynitritemediated formation of free radicals in human plasma: EPR detection of ascorbyl, albumin-thiyl and uric acid-derived free radicals. Biochem J 1996; 314:869-876.
10. Bonow RO, Mann DL, Zipes DP, Libby P. Braunwald's Heart Disease. A Textbook of Cardiovascular Medicine. 9th ed. Philadelphia, PA: Saunders; An imprint of Elsevier Inc., International Edition; 2012.
11. Rentrop KP, Cohen M, Blanke H, Phillips RA Changes in collateral channel filling immediately after controlled coronary artery occlusion by an angioplasty balloon in human subjects. J Am Coll Cardiol 1985; 5: 587-592.
12. Murphy JG, Lloyd MA. Mayo Clinic Cardiology Concise Textbook. 3rd ed. London: Mayo Foundation for Medical Education and Research; An imprint of Informa Healthcare, International Edition; 2007.
13. Rentrop KP, Thornton JC, Feit F, Van Buskirk M. Determinants and protective potential of coronary arterial collaterals as assessed by an angioplasty model. Am J Cardiol 1988; 61:677-684.
14. Schaper W, Buschmann I. Arteriogenesis, the good and bad of it [review]. Eur Heart J 1999; 20:1297-1299.
15. Arras M, Ito WD, Scholz D, Winkler B, Schaper J, Schaper W. Monocyte activation in angiogenesis and collateral growth in the rabbit hindlimb. J Clin Invest 1998; 101:40-50.
16. Bickel C, Rupprecht HJ, Blankenberg S, Rippin G, Hafner G, Daunhauer A, et al. Serum uric acid as an independent predictor of mortality in patients with angiographically proven coronary artery disease. Am J Cardiol 2002; 89:12-17.
17. Bos MJ, Koudstaal PJ, Hofman A,Witteman JC, Breteler MM. Uric acid is a risk factor for myocardial infarction and stroke: The Rotterdam study. Stroke 2006; 37:1503-1507.
18. Lazzeri C, Valente S, Chiostri M, Sori A, Bernardo P, Gensini GF. Uric acid in the acute phase of ST elevation myocardial infarction submitted to primary PCI: Its prognostic role and relation with inflammatory markers: A single center experience. Int J Cardiol 2010; 138:206-209.
19. Yildiz A, Yilmaz R, Demirbag R, Gur M, Bas MM, Erel O. Association of serum uric acid level and coronary blood flow. Coron Artery Dis 2007; 18:607-613.
20. Akpek M, Kaya MG, Uyarel H, Yarlioglues M, Kalay N, Gunebakmaz O, et al. The association of serum uric acid levels on coronary flow in patients with STEMI undergoing primary PCI. Atherosclerosis 2011; 219:334-341.
21. Schirmer SH, van Royen N, Moerland PD, Fledderus JO, Henriques JP, van der Schaaf RJ, et al. Local cytokine concentrations and oxygen pressure are related to maturation of the collateral circulation in humans. J Am Coll Cardiol 2009; 53:2141-2147.
22. Baldwin W, McRae S, Marek G, Wymer D, Pannu V, Baylis C, et al. Hyperuricemia as a mediator of the proinflammatory endocrine imbalance in the adipose tissue in a murine model of the metabolic syndrome. Diabetes 2011; 60:1258-1269.
23. Cuevas-Ramos D, Almeda-Valdes P, Gómez-Pérez FJ, Meza-Arana CE, Cruz- Bautista I, Arellano-Campos O, et al. Daily physical activity, fasting glucose, uric acid, and body mass index are independent factors associated with serum fibroblast growth factor 21 levels. Eur J Endocrinol 2010; 163: 469-477.
24. Kanellis J, Kang DH. Uric acid as a mediator of endothelial dysfunction, inflammation, and vascular disease. Semin Nephrol 2005; 25:39-42.
25. Matheus AS, TibiriçáE, da Silva PB, de Fátima Bevila'cqua da Matta M, Gomes MB. Uric acid levels are associated with microvascular endothelial dysfunction in patients with type 1 diabetes. Diabet Med 2011; 28: 1188-1193.
26. Kanbay M, Sa'nchez-Losada LG, Franco M, Madero M, Solak Y, Rodriguez- Iturbe B, et al. Microvascular disease and its role in the brain and cardiovascular system: A potential role for uric acid as a cardiorenal toxin. Nephrol Dial Transplant 2011; 26:430-437.
27. Caymaz O. Chronic heart failure and uric acid. Türk J Cardiol 2006; 9:110-114.
28. Saugstad OD. Role of xanthine oxidase and its inhibitor in hypoxia: Reoxygenation injury. Pediatrics 1996; 98:103-107.
29. Peraçoli MT, Bannwart CF, Cristofalo R, Borges VT, Costa RA, Witkin SS, Peraçoli JC. Increased reactive oxygen species and tumor necrosis factoralpha production by monocytes are associated with elevated levels of uric acid in pre-eclamptic women. Am J Reprod Immunol 2011; 66:460-467.
30. Yun J, Rocic P, Pung YF, Belmadani S, Carrao AC, Ohanyan V, Chilian WM. Redox-dependent mechanisms in coronary collateral growth: The 'redox window' hypothesis. Antioxid Redox Signal 2009; 11:1961-1974.
31. Rocic P, Kolz C, Reed R, Potter B, Chilian WM. Optimal reactive oxygen species concentration and p38 MAP kinase are required for coronary collateral growth. Am J Physiol Heart Circ Physiol 2007; 292:H2729-H2736.
32. Rockstroh J, Brown BG. Coronary collateral size, flow capacity, and growth: Estimates from the angiogram in patients with obstructive coronary disease. Circulation 2002; 105:168-173.
33. Arnold WL, DeWall RA, Kezdi P, Zwart HH. The effect of allopurinol on the degree of early myocardial ischemia. Am Heart J 1980; 99:614-624.
34. Freidl HP, Smith DJ, Till GO. Ischaemia-reperfusion in humans: Appearance of xanthine oxidase activity. Am J Pathol 1990; 136:491-495.